aori造句

• The shares are expected to list on the Nasdaq under the symbol AORI . Alex.
• -- American Oncology Resources ( AORI US ) was rated " outperform " in new coverage by analyst Elizabeth Senko at Lehman Brothers.
• -- American Oncology Resources Inc . ( AORI ) was rated " buy " in new coverage by analyst Mark Banta at Salomon Brothers.
• -- American Oncology Resources ( AORI US ) was rated " buy " in new coverage by analyst J . Chris Sergeant at Dain Bosworth.
• -- American Oncology Resources ( AORI US ) was rated " buy " in new coverage by analyst John Ransom at Raymond James Financial Inc.
• -- American Oncology Resources ( AORI US ) was rated " buy " in new coverage by analyst Lawrence C . Marsh at Salomon Brothers.
• -- American Oncology Resources ( AORI US ) was rated " neutral " in new coverage by analyst Gary Frazier at Bear Stearns & Co.
• -- American Oncology Resources ( AORI US ) was raised to " buy " from " outperform " by analyst Elizabeth Senko at Lehman Brothers.
• -- American Oncology Resources ( AORI US ) was raised to " strong buy " from " buy " by analyst David Childe at Salomon Brothers.
• -- American Oncology Resources ( AORI US ) was rated " buy " in new coverage by analyst Kim Hollingsworth Taylor at Wessels Arnold & Henderson.
• -- American Oncology Resources ( AORI US ) was raised to " strong buy " from " buy " by analyst Eleanor H . Kerns at Alex.
• -- American Oncology Resources ( AORI US ) was downgraded to " market outperform " from " focus buy " by analyst Kurt Fish at Rauscher Pierce Refnes.
• -- American Oncology Resources ( AORI US ) was raised to " focus buy " from " market outperform " by analyst Kurt Fish at Rauscher Pierce Refnes.
• -- American Oncology Resources ( AORI US ) was raised to " strong buy " fro " buy " by analyst Bernard Lirola at Needham & Co.
• -- American Oncology Resources ( AORI US ) was raised to " strong buy " from " buy " by analyst Bernard Lirola at Needham & Co.
• -- American Oncology Resources ( AORI US ) was raised to " strong buy " from " buy " by analyst Jason Rosenbluth at Merrill Lynch & Co.
• -- American Oncology Resources Inc . ( AORI ) was rated short-term and long-term " strong buy " in new coverage by analyst Bharat V . Pandya at Southcoast Capital Corp.
• -- American Oncology Resources ( AORI US ) was raised to long-term " strong buy " from long-term " buy " by analysts Maureen McEnroe and Anne B . Reese at Southcoast Capital Corp.
• -- American Oncology Resources ( AORI US ) was rated medium-term " neutral'in new coverage by analyst Kenneth Weakley at Merrill Lynch & Co . The new long-term rating was " accumulate ."
• -- American Oncology Resources ( AORI US ) was rated medium-term " neutral " in new coverage by analyst Kenneth Weakley at Merrill Lynch & Co . The new long-term rating was " accumulate ."